SG50505A1 - Melatonin derivatives for use in treating sleep disorders - Google Patents

Melatonin derivatives for use in treating sleep disorders

Info

Publication number
SG50505A1
SG50505A1 SG1996002927A SG1996002927A SG50505A1 SG 50505 A1 SG50505 A1 SG 50505A1 SG 1996002927 A SG1996002927 A SG 1996002927A SG 1996002927 A SG1996002927 A SG 1996002927A SG 50505 A1 SG50505 A1 SG 50505A1
Authority
SG
Singapore
Prior art keywords
sleep disorders
treating sleep
melatonin derivatives
melatonin
derivatives
Prior art date
Application number
SG1996002927A
Other languages
English (en)
Inventor
Michael Edward Flaugh
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SG50505A1 publication Critical patent/SG50505A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG1996002927A 1993-11-18 1994-11-16 Melatonin derivatives for use in treating sleep disorders SG50505A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/154,332 US5654325A (en) 1993-11-18 1993-11-18 Melatonin derivatives for use in treating sleep disorders

Publications (1)

Publication Number Publication Date
SG50505A1 true SG50505A1 (en) 1998-07-20

Family

ID=22550932

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996002927A SG50505A1 (en) 1993-11-18 1994-11-16 Melatonin derivatives for use in treating sleep disorders

Country Status (21)

Country Link
US (1) US5654325A (ko)
EP (1) EP0655243B1 (ko)
JP (1) JPH07196493A (ko)
KR (1) KR950013508A (ko)
CN (1) CN1092958C (ko)
AT (1) ATE222491T1 (ko)
AU (1) AU684313B2 (ko)
CA (1) CA2135709C (ko)
CZ (1) CZ288835B6 (ko)
DE (1) DE69431199T2 (ko)
DK (1) DK0655243T3 (ko)
ES (1) ES2181702T3 (ko)
HU (1) HUT72069A (ko)
IL (1) IL111580A (ko)
NO (1) NO309964B1 (ko)
NZ (1) NZ264892A (ko)
PH (1) PH31098A (ko)
PT (1) PT655243E (ko)
RU (1) RU2146140C1 (ko)
SG (1) SG50505A1 (ko)
ZA (1) ZA948927B (ko)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0748627A3 (en) * 1995-06-14 1997-05-21 Lilly Co Eli Melatonin agonists for the treatment of benign forms of hyperplasia of the prostate
CA2357114C (en) * 2001-03-22 2010-06-29 Pooger Properties Ltd. Use of melatonin in the manufacture of a medicament for treating attention deficit hyperactive disorder
WO2002079153A1 (en) * 2001-03-28 2002-10-10 Biocatalytics, Inc. Method for producing tryptamine derivatives
IL144900A (en) * 2001-08-14 2013-12-31 Neurim Pharma 1991 Melatonin and drugs containing it for use in the treatment of primary insomnia, and the manufacture of those drugs
US20060167050A1 (en) * 2002-09-26 2006-07-27 Pooger Properties Limited Combined use of methylphenidate and melatonin for treating attention-deficit hyperactive disorder
JP4933097B2 (ja) 2003-12-19 2012-05-16 株式会社メニコン 糖尿病および糖尿病合併症の治療・改善方法
US20070105937A1 (en) * 2003-12-22 2007-05-10 Miguel Pappolla Indole-3-propionamide and derivatives thereof
EP1715742A4 (en) * 2004-02-20 2009-06-17 Lifescape Biosciences Inc COMPOSITIONS AND METHODS FOR SLEEPING
DE102005008312A1 (de) * 2005-02-17 2006-08-24 Birds Pharma Gmbh Berolina Innovative Research & Development Services Verwendung deuterierter N-[2-(5-Methoxy-1H-indol-3-yl)-ethyl]acatamide und deren pharmazeutisch verträglicher Salze sowie diese Verbindungen enthaltende Arzneimittel
US20060223877A1 (en) * 2005-03-31 2006-10-05 Zemlan Frank P Methods of treatment utilizing certain melatonin derivatives
TWI402261B (zh) 2006-06-19 2013-07-21 Takeda Pharmaceutical 三環化合物及其醫藥組成物
ES2324849A1 (es) * 2007-10-25 2009-08-17 Ferrer Internacional, S.A. Compuestos de indano.

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087444A (en) * 1976-09-08 1978-05-02 Eli Lilly And Company Amides as ovulation inhibitors
IT1148618B (it) * 1982-10-11 1986-12-03 Polifarma Spa Procedimento enzimatico per la produzione di acido 3-indolpiruvico e utilizzazione farmaceutica di questo
US4600723A (en) * 1983-05-18 1986-07-15 Monash University Method for minimizing disturbances in circadian rhythms of bodily performance and function
DE3466215D1 (en) * 1983-05-18 1987-10-22 Univ Monash The use of melatonin for the manufacture of a medicament
US4614807A (en) * 1984-10-04 1986-09-30 Eli Lilly And Company 6,7-dihalomelatonins
US4687763A (en) * 1985-02-25 1987-08-18 Massachusetts Institute Of Technology Composition and method for increasing levels or release of brain serotonin
US4997845A (en) * 1987-02-02 1991-03-05 Eli Lilly And Company β-alkylmelatonins as ovulation inhibitors
US5093352A (en) * 1988-11-14 1992-03-03 Whitby Research, Inc. Antidepressant agents
EP0375726A4 (en) * 1987-08-17 1991-01-30 Whitby Research Incorporated Melatonin analogues
JPH0418034A (ja) * 1990-05-11 1992-01-22 Kanegafuchi Chem Ind Co Ltd 点眼組成物
US5242941A (en) * 1990-12-04 1993-09-07 State Of Oregon Methods of treating circadian rhythm disorders
IT1251544B (it) * 1991-05-13 1995-05-17 Gabriele Biella Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico
JPH07503232A (ja) * 1991-10-18 1995-04-06 アルザ・コーポレーション メラトニンの制御経皮投与
US5196435A (en) * 1991-11-21 1993-03-23 Eli Lilly And Company Melatonin derivatives and combinations with antiestrogen compounds for treating mammalian breast carcinoma
IT1255199B (it) * 1992-07-01 1995-10-20 Franco Fraschini Farmaco sintetizzato analogo della melatonina particolarmente efficacenelle patologie che interferiscono con i ritmi circadiani
IT1254995B (it) * 1992-06-24 1995-10-11 Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani
US5449683A (en) * 1992-10-01 1995-09-12 Massachussetts Institute Of Technology Methods of inducing sleep using melatonin

Also Published As

Publication number Publication date
CN1107701A (zh) 1995-09-06
CN1092958C (zh) 2002-10-23
DE69431199D1 (de) 2002-09-26
NO944339L (no) 1995-05-19
ATE222491T1 (de) 2002-09-15
CA2135709C (en) 2007-01-02
ES2181702T3 (es) 2003-03-01
EP0655243A3 (en) 1995-10-11
IL111580A (en) 1999-10-28
US5654325A (en) 1997-08-05
RU94040886A (ru) 1996-09-20
CZ288835B6 (cs) 2001-09-12
PH31098A (en) 1998-02-05
AU7777794A (en) 1995-05-25
DK0655243T3 (da) 2002-10-07
CZ276594A3 (en) 1995-07-12
DE69431199T2 (de) 2003-03-27
EP0655243B1 (en) 2002-08-21
RU2146140C1 (ru) 2000-03-10
PT655243E (pt) 2002-11-29
NO309964B1 (no) 2001-04-30
HU9403300D0 (en) 1995-01-30
KR950013508A (ko) 1995-06-15
ZA948927B (en) 1996-05-10
AU684313B2 (en) 1997-12-11
HUT72069A (en) 1996-03-28
EP0655243A2 (en) 1995-05-31
NO944339D0 (no) 1994-11-14
JPH07196493A (ja) 1995-08-01
IL111580A0 (en) 1995-01-24
CA2135709A1 (en) 1995-05-19
NZ264892A (en) 1997-07-27

Similar Documents

Publication Publication Date Title
HK1028206A1 (en) Use of four k-252a derivatives
GB2227103B (en) Laser apparatus for medical treatment
LTIP919A (en) Drugs and process for preparing thereof
IL107248A0 (en) Apparatus for treatment of the oral cavity
EP0713699A3 (ko)
GB2146527B (en) Use of benzothiophene derivatives as antiasthmatic agents
SG50505A1 (en) Melatonin derivatives for use in treating sleep disorders
SG77569A1 (en) Melatonin derivatives for use in treating desynchronization disorders
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
IL105475A0 (en) Pharmaceutical compositions containing 1alpha,24(r)-dihydroxy-22(e)-dehydro-vitamin d3 for treating osteoporosis
RU2004219C1 (ru) Устройство дл выт жени шейного отдела позвоночника
GB2280371B (en) Surface sterilisation by laser treatment
AU4973690A (en) Apparatus for treatment of disorders